Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasopressin.

Cheryl L Holmes1, James A Russell

  • 1Department of Medicine, University of British Columbia, Kelowna, British Columbia, Canada.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary
This summary is machine-generated.

Vasopressin replacement therapy shows promise for treating vasodilatory shock, including septic shock, by restoring vascular tone. Further randomized trials are needed to confirm its routine use in managing septic shock.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Scientific reports·2026
Same author

Association between COVID-19 vaccination, SARS-CoV-2 variants, and post COVID-19 condition: A cross-sectional study.

PloS one·2025
Same author

Brain Death/Death by Neurologic Criteria Guidance on Communication, Objections, Pregnancy, and Public Trust: An AAN Position Statement.

Neurology·2025
Same author

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Scientific reports·2025
Same author

Divergent biological pathways distinguish community-acquired pneumonia from COVID-19 despite similar plasma cytokine profiles.

Respiratory research·2025
Same author

Obesity- and Lipid-Related Traits May Causally Contribute to Sepsis-Associated Acute Kidney Injury.

Critical care medicine·2025
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Area of Science:

  • Endocrinology
  • Cardiovascular Physiology
  • Critical Care Medicine

Background:

  • Vasopressin is crucial for maintaining osmotic and cardiovascular homeostasis.
  • Vasopressin deficiency occurs in certain shock states, leading to loss of vascular tone.
  • Restoring physiological vasopressin levels can improve vascular tone.

Purpose of the Study:

  • To review the rationale for using vasopressin in vasodilatory shock.
  • To summarize existing evidence for vasopressin in treating conditions like septic shock.
  • To identify uncertainties and areas of clinical equipoise regarding vasopressin use.

Main Methods:

  • Literature review of vasopressin's role in shock states.
  • Analysis of evidence supporting vasopressin therapy in vasodilatory and septic shock.

Related Experiment Videos

  • Discussion of clinical equipoise and areas needing further investigation.

    • Main Results:

    • Vasopressin is emerging as a rational therapeutic option for vasodilatory shock.
    • Evidence suggests potential benefits in restoring vascular tone in shock.
    • Significant uncertainties remain regarding optimal use in septic shock.

    Conclusions:

    • Vasopressin therapy is a promising approach for vasodilatory shock.
    • Clinical equipoise exists regarding its routine application in septic shock.
    • Further randomized controlled trials are necessary before widespread adoption for septic shock management.